Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis
Open accessAbstract
BACKGROUND: Amphetamine and methamphetamine use disorders are associated with severe health and social consequences. No pharmacological therapy has been approved for the treatment of these disorders. Psychostimulants can act as maintenance-like therapies for managing substance use among these patients. The aim of this study is to evaluate the literature examining the efficacy and safety of psychostimulant agents for increasing abstinence and treatment retention among patients with amphetamine and methamphetamine use disorders. METHODS: We searched MEDLINE, EMBASE, PsycInfo, Cochrane Central, and CINAHL from inception to August 2016. Selection of studies, data extraction, and risk of bias assessment were conducted independently by two reviewers. We conducted meta-analyses to provide a pooled summary estimate for included trials and report the review according to PRISMA guidelines. RESULTS: We identified and selected 17 studies with 1387 participants. Outcome reporting across trials was inconsistent, and the overall quality of evidence was very low due to high risk of bias and indirectness. A meta-analysis of five trials (642 participants) found no effect of psychostimulants for end-of-study abstinence (odds ratio = 0.97, 95% confidence interval 0.65 to 1.45). Additionally, the pooled estimate from 14 studies (1184 participants) showed no effect of psychostimulants for treatment retention (odds ratio = 1.20, 95% confidence interval = 0.91 to 1.58). The incidence of serious adverse events did not differ between intervention and placebo groups based on qualitative reports from trials. CONCLUSIONS: Quantitative analyses showed no effect of psychostimulants for sustained abstinence or treatment retention. We also identified the need for more rigorous studies in this research area with clinician and patient important outcomes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The included systematic review [108] concluded there was no evidence of an effect of psychostimulants on terminal abstinence and treatment retention in the context of amphetamine and methamphetamine use disorder.
“Review authors from both SRs concluded that there was no evidence of an effect of psychostimulants on terminal abstinence (i.e., maintaining abstinence from methamphetamine at the end of the trial) and treatment retention in the context of amphetamine and methamphetamine use disorder [108]”
From Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature (2023) · cites this paper as [108]
Using AMSTAR-2, the systematic review [108] was rated low quality due to one critical flaw and two non-critical weaknesses.
“Using the AMSTAR-2 instrument (assessments provided in S6 Text), one review was rated to be of low quality [108] due to the presence of one critical flaw (i.e., did not provide a list of studies evaluated at full-text that were excluded) and two non-critical weaknesses (i.e., did not describe for inclusion of study designs, did not perform data extraction in duplicate);”
From Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature (2023) · cites this paper as [108]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554 · see citing works
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · see citing works
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,577 · see citing works
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
Users' guides to the medical literature : a manual for evidence-based clinical practice
Guyatt, G. H., Rennie, D., Meade, M. O., & Cook, D. J. (2002) · Cited by 1,196 · see citing works
Major physical and psychological harms of methamphetamine use
DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801923702 · Cited by 675 · see citing works
Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS)
Hubbard, R. L., Craddock, S. G., & Anderson, J. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00130-2 · Cited by 410 · see citing works
Users’ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice
Kleinbart, J., & Williams, M. V. (2002) · Evidence-Based Mental Health · doi:10.1136/ebmh.5.4.103 · Cited by 355 · see citing works
Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence
Grabowski, J. G., Shearer, J., Merrill, J., & Negus, S. S. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.018 · Cited by 257 · see citing works
A systematic review of cognitive and behavioural therapies for methamphetamine dependence
Lee, N., & Rawson, R. A. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801919494 · Cited by 255 · see citing works
Pharmacological approaches to methamphetamine dependence: a focused review
Karila, L., Weinstein, A., Aubin, H., Benyamina, A., Reynaud, M., & Batki, S. L. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03639.x · Cited by 242 · see citing works
Bupropion for the treatment of methamphetamine dependence
Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S.-H., Holmes, T., Smith, E. V., Chiang, N., Kahn, R., Vocci, F., Ling, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301481 · Cited by 234 · see citing works
Methamphetamine use among young adults: Health and social consequences
Sommers, I. B., Baskin, D. R., & Baskin–Sommers, A. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.10.004 · Cited by 199 · see citing works
Konstenius, M., Jayaram‐Lindström, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2014) · Addiction · doi:10.1111/add.12369 · Cited by 188 · see citing works
A Comparison of Aripiprazole, Methylphenidate, and Placebo for Amphetamine Dependence
Tiihonen, J., Kuoppasalmi, K. I., Föhr, J., Tuomola, P., Kuikanmäki, O., Vorma, H., Sokero, P., Haukka, J. K., & Meririnne, E. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.160 · Cited by 178 · see citing works
A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence
Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., McKetin, R., Mattick, R. P., & Wodak, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02437.x · Cited by 159 · see citing works
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
SHOPTAW, S. J., Heinzerling, K. G., Rotheram-Fuller, E. J., Steward, T., Wang, J., Swanson, A., Garza, R. D. L., Newton, T., & Ling, W. W. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.010 · Cited by 150 · see citing works
Efficacy of Psychostimulant Drugs for Cocaine Dependence
Cervelló, X. C., Casas, M., Pérez‐Mañá, C., Roncero, C., Vidal, X., & Capellà, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007380.pub3 · Cited by 130 · see citing works
Longo, M., Wickes, W., Smout, M., Harrison, S., Cahill, S., & White, J. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02717.x · Cited by 122 · see citing works
Thompson, T., Greaves, C. J., Ayres, R., Aveyard, P. N., Warren, F. C., Byng, R., Taylor, R. S., Campbell, J. L., USSHER, M. H., Michie, S., et al. (2015) · Trials · doi:10.1186/1745-6215-16-1 · Cited by 120 · see citing works
Modafinil for the treatment of methamphetamine dependence
Anderson, A. L., Li, S.-H., Biswas, K., McSherry, F., Holmes, T. H., Iturriaga, E., Kahn, R., Chiang, N., Beresford, T. P., Campbell, J. L., et al. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.07.007 · Cited by 117 · see citing works
Heinzerling, K. G., Swanson, A.-N., Kim, S., Cederblom, L., Moe, A., Ling, W., & Shoptaw, S. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.023 · Cited by 105 · see citing works
Galloway, G., Buscemi, R., Coyle, J., Flower, K., Siegrist, J. D., Fiske, L. A., Baggott, M. J., Li, L., Polcin, D. L., Chen, C. A., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.307 · Cited by 103 · see citing works
Efficacy of psychostimulant drugs for amphetamine abuse or dependence
Pérez‐Mañá, C., Cervelló, X. C., Torrens, M., Capellà, D., & Farré, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009695.pub2 · Cited by 93 · see citing works
Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: A pilot study
Konstenius, M., Jayaram-Lindström, N., Beck, O., & Franck, J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.006 · Cited by 83 · see citing works
Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder
Ling, W. W., Chang, L., Hillhouse, M. P., Ang, A., Striebel, J. M., Jenkins, J., Hernandez, J. C., Olaer, M., Mooney, L. J., Reed, S. W., et al. (2014) · Addiction · doi:10.1111/add.12608 · Cited by 81 · see citing works
The burden and management of crystal meth use
Buxton, J. A., & Dove, N. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071234 · Cited by 81 · see citing works
Anderson, A. L., Li, S.-H., Markova, D., Holmes, T. H., Chiang, N., Kahn, R., Campbell, J., Dickerson, D. L., Galloway, G. P., Haning, W., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.036 · Cited by 70 · see citing works
Heinzerling, K. G., Swanson, A., Hall, T. M., Yi, Y., Wu, Y., & Shoptaw, S. J. (2014) · Addiction · doi:10.1111/add.12636 · Cited by 64 · see citing works
Psychosocial approaches to psychostimulant dependence: A systematic review
Shearer, J. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.06.012 · Cited by 64 · see citing works
Miles, S. W., Sheridan, J., Russell, B., Kydd, R., Wheeler, A., Walters, C., Gamble, G., Hardley, P., Jensen, M., Kuoppasalmi, K., et al. (2013) · Addiction · doi:10.1111/add.12109 · Cited by 63 · see citing works
Rezaei, F., Emami, M., Zahed, S., Morabbi, M.-J., Farahzadi, M., & Akhondzadeh, S. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-015-0092-y · Cited by 51 · see citing works
Dennis, B. B., Roshanov, P. S., Naji, L., Bawor, M., Paul, J., Plater, C., Paré, G., Worster, A., Varenbut, M., Daiter, J., et al. (2015) · Trials · doi:10.1186/s13063-015-0942-4 · Cited by 41 · see citing works
Reanalysis of Methamphetamine Dependence Treatment Trial
Winchell, C., Rappaport, B. A., Roca, R. A., & Rosebraugh, C. J. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00288.x · Cited by 39 · see citing works
A review of psychological and pharmacological treatment options for methamphetamine dependence
Ciketic, S., Hayatbakhsh, M. R., Doran, C. M., Najman, J. M., & McKetin, R. (2012) · Journal of Substance Use · doi:10.3109/14659891.2011.592900 · Cited by 36 · see citing works
Pérez-Mañá, C., Castells, X., Vidal, X., Casas, M., & Capellà, D. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.08.012 · Cited by 33 · see citing works
Das, M., Santos, D., Matheson, T., Santos, G., Chu, P. L., Vittinghoff, E., SHOPTAW, S. J., & Colfax, G. N. (2010) · AIDS · doi:10.1097/qad.0b013e328336e98b · Cited by 32 · see citing works
Pilot Randomized Trial of Bupropion for Adolescent Methamphetamine Abuse/Dependence
Heinzerling, K. G., Gadzhyan, J., van Oudheusden, H., Rodriguez, F., McCracken, J. T., & SHOPTAW, S. J. (2013) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2012.10.275 · Cited by 26 · see citing works
di Ruffano, L. F., Dinnes, J., Phillips-Taylor, S., Davenport, C. F., Hyde, C., & Deeks, J. J. (2015) · Trials · doi:10.1186/1745-6215-16-s2-o31 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Treatment of stimulant use disorder: A systematic review of reviews
Ronsley, C., Nolan, S., Knight, R., Hayashi, K., Klimas, J., Walley, A., Wood, E., & Fairbairn, N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234809 · Cited by 222 · see citing works
Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta‐analysis
Chan, B., Freeman, M., Kondo, K., Ayers, C., Montgomery, J., Paynter, R., & Kansagara, D. (2019) · Addiction · doi:10.1111/add.14755 · Cited by 160 · see citing works
Naji, L., Dennis, B. B., Rosic, T., Wiercioch, W., Paul, J., Worster, A., Thabane, L., & Samaan, Z. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109295 · Cited by 47 · see citing works
Kohno, M., Dennis, L. E., McCready, H. D., & Hoffman, W. F. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01180-4 · Cited by 42 · see citing works
Forouzan, S., Hoffman, K. L., & Kosten, T. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05681-y · Cited by 39 · see citing works
Methamphetamine Toxicities and Clinical Management
Coffin, P. O., & Suen, L. W. (2023) · NEJM Evidence · doi:10.1056/evidra2300160 · Cited by 36 · see citing works
Sharafi, H., Bakouni, H., McAnulty, C., Drouin, S., Coronado‐Montoya, S., Bahremand, A., Bach, P., Ezard, N., Foll, B. L., Schütz, C. G., et al. (2023) · Addiction · doi:10.1111/add.16347 · Cited by 28 · see citing works
Elbatarny, M., Bahji, A., Bisleri, G., & Hamilton, A. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.01.008 · Cited by 29 · see citing works
Harney, B. L., Brereton, R., Whitton, B., Pietrzak, D., Paige, E. K., Roberts, S. K., Birks, S., Saraf, S., Hellard, M. E., & Doyle, J. (2021) · Journal of Viral Hepatitis · doi:10.1111/jvh.13487 · Cited by 29 · see citing works
Goodman‐Meza, D., SHOPTAW, S. J., Weiss, R. E., Nakazono, T. T., Harawa, N. T., Takada, S., Garland, W., & Cunningham, W. E. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.05.007 · Cited by 28 · see citing works
Shokoohi, M., Karamouzian, M., Sharifi, H. P., Rahimi‐Movaghar, A., Carrico, A. W., Hooshyar, S. H., & Mirzazadeh, A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.12.025 · Cited by 26 · see citing works
Bakouni, H., Sharafi, H., Bahremand, A., Drouin, S., Ziegler, D., Bach, P., Foll, B. L., Schütz, C. G., Tardelli, V. S., Ezard, N., et al. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111018 · Cited by 23 · see citing works
Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial
Stauffer, C. S., Moschetto, J. M., McKernan, S. M., Meinzer, N. K., Chiang, C., Rapier, R., Hsiang, E., Norona, J. C., Borsari, B. E., & Woolley, J. D. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108059 · Cited by 21 · see citing works
Amphetamine Related Psychiatric Disorders
Mullen, J. M., Richards, J. R., & Crawford, A. (2019) · StatPearls · Cited by 21 · see citing works
McKetin, R., Dean, O. M., Turner, A., Kelly, P. J., Quinn, B., Lubman, D. I., Dietze, P., Carter, G. L., Higgs, P., Baker, A., et al. (2019) · Trials · doi:10.1186/s13063-019-3450-0 · Cited by 18 · see citing works
Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Esmaeilisaraji, L., et al. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01499-z · Cited by 17 · see citing works
Continuing Increase in Stimulant Dependence – Time to Implement Medical Treatment
Bisaga, A. M., Tardelli, V. S., Gerra, G., Busse, A., Campello, G., Kashino, W., Sáenz, E., & Fidalgo, T. M. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221083505 · Cited by 15 · see citing works
Update on methamphetamine: an old problem that we have recently encountered
Evren, C., & Bozkurt, M. (2018) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn20183101001 · Cited by 14 · see citing works
Hersi, M., Corace, K., Hamel, C., Esmaeilisaraji, L., Rice, D., Dryburgh, N., Skidmore, B., Garber, G., Porath, A., Willows, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292745 · Cited by 13 · see citing works
Arkell, T. R., Bradshaw, K., Downey, L. A., & Hayley, A. C. (2022) · Addiction Biology · doi:10.1111/adb.13128 · Cited by 12 · see citing works
Khalili, M., Sadeghirad, B., Bach, P., Crabtree, A., Javadi, S., Sadeghi, E., Moradi, S., Fashami, F. M., Nakhaeizadeh, M., Salehi, S., et al. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01379-w · Cited by 15 · see citing works
Bahji, A., Danilewitz, M., & Crockford, D. N. (2021) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000110 · Cited by 11 · see citing works
Rodger, L., Cygler, J., & Pinto, A. D. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2350696 · Cited by 10 · see citing works
Management of withdrawal from alcohol and other drugs
Lintzeris, N., Sunjic, S., Demirkol, A., Branezac, M., Ezard, N., Siefried, K. J., Acheson, L. S., Bascombe, F., Tremonti, C., & Haber, P. (2019) · doi:10.57022/mjjp9930 · Cited by 9 · see citing works
Elkrief, L., Sharafi, H., Bakouni, H., McAnulty, C., Bastien, G., Dubreucq, S., Garel, N., Trépanier, A., Ziegler, D., & Jutras‐Aswad, D. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241262967 · Cited by 7 · see citing works
Zhang, J., Chen, T., Tan, H., Wu, Q., Chen, L., Yuan, C., Ding, X., Zhang, L., Du, C., Li, J., et al. (2022) · Mindfulness · doi:10.1007/s12671-022-01882-y · Cited by 7 · see citing works
Gao, Z., Winhusen, T. M., Gorenflo, M. P., Dorney, I., Ghitza, U. E., Kaelber, D. C., & Xu, R. (2024) · Addiction · doi:10.1111/add.16715 · Cited by 6 · see citing works
Bahji, A. (2020) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-020-00230-2 · Cited by 5 · see citing works
Bahji, A. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241312683 · Cited by 5 · see citing works
Guaiana, G., Goodman, M., Tippett, M., & Gale, C. K. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2212386 · Cited by 5 · see citing works
Identifying and Managing Eating Disorders in Persons Presenting for Addiction Treatment
Norris, T., Dahl, P., Jericho, M., & Crockford, D. N. (2021) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000129 · Cited by 4 · see citing works
Silva, G. R., Costa, R. A. R., Lopes, P. Q., Ferreira, J. R. O., Junior, A., & Magalhães, H. I. F. (2018) · Revista Brasileira de Criminalística · doi:10.15260/rbc.v7i3.265 · Cited by 4 · see citing works
Sahaf, S. M. S., Yazdi, A. S. H., Ramezani, F., & Kamrani, M. (2024) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba-146021 · Cited by 3 · see citing works
Role of stimulant replacement therapy in treating stimulant use disorders
Mak, W., Webb, D., Sutherland, C., & Hirsh, A. (2022) · Canadian Family Physician · doi:10.46747/cfp.6802109 · Cited by 3 · see citing works
Lustig, A., & Brookes, G. (2023) · JMIR Infodemiology · doi:10.2196/48189 · Cited by 2 · see citing works
Chalabianloo, F., Fadnes, L. T., Mordal, J., Spigset, O., Løberg, E., Halmøy, A., Lid, T. G., Andersen, C. D., Daltveit, J. T., Aßmus, J., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-095383 · Cited by 2 · see citing works
Yue, J.-L., Wang, R., Chen, S., Lin, X., Fang, Q., Guo, X.-J., Sun, Y., Yuan, K., Bao, Y., Shi, J., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03474-5 · Cited by 3 · see citing works
Methamphetamine-Induced Psychosis
Crockford, D. N., Meunier, S., & Ghosh, S. M. (2019) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000068 · Cited by 2 · see citing works
THE DEVELOPMENT OF THE MARKET ECONOMY IN COLONIAL MASSACHUSETTS
Weiss, R. S. (1981) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · Cited by 2 · see citing works
Wagner, K. D., Marks, C., Fiuty, P., Harding, R. W., & Page, K. A. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00401-1 · Cited by 1 · see citing works
Bach, P., Stenger, M., & Ersche, K. D. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01687-5 · Cited by 1 · see citing works
Diagnosis and Management of Comorbid ADHD in Patients with Substance Use Disorders
Busch, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-72219-6_50 · Cited by 1 · see citing works
Kamrani, M., Moharreri, F., Sahaf, S. M. S., Khalesi, A., & Davoudipour, Z. (2025) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba-166947 · Cited by 1 · see citing works
Characteristics of Amphetamine Psychosis with Respect to the Length of Drug Exposure
Sokolova, I. M., Babina, A., & Vysotskyi, M. M. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220726141936 · Cited by 1 · see citing works
Dangerous trend of methamphetamine use among youths in south-eastern Nigeria: A mini-review
Mbanuzuru, A. V., Oriji, S. O., Udigwe, I. B., Onu, J. U., Ifeadike, C. O., & Ibeh, C. C. (2022) · International Journal of Research in Psychiatry · doi:10.22271/27891623.2022.v2.i1a.26 · Cited by 1 · see citing works
Delphi method applicability in drug foresight
Lintonen, T., Karjalainen, K., Rönkä, S., Kotovirta, E., & Niemelä, S. (2024) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-024-00617-7 · Cited by 1 · see citing works
Commentary on Stockings et al . (2019): The global amphetamine epidemic — a rising tide of mortality
Bahji, A. (2019) · Addiction · doi:10.1111/add.14739 · Cited by 1 · see citing works
Moreira, K. S. T., Gomes, C. M., & Costa, S. H. N. (2020) · Revista Brasileira Militar de Ciências · doi:10.36414/rbmc.v6i15.47
Lobato, J. C. P., Lobato, R. M. C., Lobato, E. S. D., Parente, M. V. M., Pereira, P. H. P., Duarte, P. L. P., & Furlaneto, I. P. (2024) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e15109.2024
(2025) · Wiley eBooks · doi:10.1002/9781118941430.refs
Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Esmaeilisaraji, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13141762
Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Esmaeilisaraji, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13141777
Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Esmaeilisaraji, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13141774
Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., MacPherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Esmaeilisaraji, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13141765
Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Esmaeilisaraji, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13141771
Assessment of dermal permeation of methamphetamine hydrochloride in human skin
He, C., Zheng, Q., Espartero, L. J. L., Yamada, M., Moore, M., Prow, T. W., & Thai, P. K. (2026) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2026.101280
- Authors
- Bhatt, M., Zielinski, L., Baker-Beal, L., Bhatnagar, N., Mouravska, N., Laplante, P., Worster, A., Thabane, L., & Samaan, Z.
- Affiliations
- McMaster University (CA)
- St George's, University of London (GB)
- Juravinski Hospital (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- Peter Boris Centre for Addictions Research (CA)
- Corresponding author
- Samaan, Zainab
- Venue
- Systematic Reviews
- Published
- 2016-11-14
- Volume
- 5
- Issue
- 1
- Pages
- 189-189
- ISSN
- 2046-4053 (ISSN-L)
- PMC
- PMC5109734
- OpenAlex
- W2555084569
- Cited by
- 56
- References
- 42
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 4 · 2020: 11 · 2019: 8 · 2018: 3
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Systematic Reviews (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Hamilton Academic Health Sciences Organization (HAH-16-04)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- psychostimulants, amphetamine use disorder, methamphetamine dependence, addiction treatment, abstinence, treatment retention, adverse events, maintenance therapy
- MeSH terms
- Central Nervous System Stimulants, Humans, Methamphetamine, Amphetamine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
